Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 5Lung Neoplasms 4Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Recurrence 2Neoplasm Metastasis 2Malignant Neoplasms of Independent (Primary) Multiple Sites 2Lung Diseases 2Head and Neck Neoplasms 2cyclopia sequence 1Tobacco Use Cessation 1Smoke Inhalation Injury 1Sezary Syndrome 1Seroma 1Sarcoma 1Respiratory Aspiration 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyneuropathies 1Peripheral Nervous System Diseases 1Patient Education 1Pain 1Ovarian Neoplasms 1Occupational Stress 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Mouth Neoplasms 1Mesothelioma 1Malignant Neoplasms of Female Genital Organs 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Surveys and Questionnaires 1Quercetin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Polyneuropathies × Surveys and Questionnaires × Clear all
NCT02989129 2018-04-18

Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Withdrawn

Polyneuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡